Valuation : Oscotec Inc.

Market Cap 1,335B 996M 858M 813M 737M 1.38B 95.16B 1.39B 9.65B 3.71B 48.41B 3.74B 3.66B 153B P/E 2026 *
41.5x
P/E 2027 * 11.2x
Enterprise Value 1.15B 858K 739K 700K 635K 1.19M 81.98M 1.2M 8.31M 3.2M 41.71M 3.22M 3.15M 132M EV / Sales 2026 *
13.7x
EV / Sales 2027 * 5.37x
Free-Float
71.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.55%
1 week-4.64%
Current month-0.43%
1 month-8.88%
3 months-10.74%
6 months-37.79%
Current year-22.79%
1 week 33,650
Extreme 33650
36,100
1 month 33,650
Extreme 33650
40,000
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 63 25/03/2020
Corporate Officer/Principal 54 31/08/1999
Chief Tech/Sci/R&D Officer 63 -
Director TitleAgeSince
Director/Board Member 54 31/08/1999
Director/Board Member 63 25/03/2020
Director/Board Member 66 29/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
24/07/25 Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%-4.64%-19.77%+23.32% 996M
-0.54%-4.26%+73.81%+33.50% 355B
-0.15%-3.24%+23.14%-17.84% 66.33B
+0.19%-2.71%+39.40%+161.27% 12.17B
+1.37%-7.05%-7.44%-17.63% 7.47B
-4.80%-8.31%-28.47%-8.74% 4.64B
+0.63%-2.46%-33.67%+12.81% 4.42B
-1.24%-6.98%-35.59%-10.53% 2.86B
-0.12%-4.34%-8.40%+38.66% 2.42B
-1.84%-5.00%-28.40%-26.72% 1.9B
Average -0.80%-4.44%-2.54%+18.81% 45.83B
Weighted average by Cap. -0.47%-4.15%+60.42%+27.48%

Financials

2026 *2027 *
Net sales 84B 62.67M 53.99M 51.12M 46.34M 86.93M 5.99B 87.37M 607M 233M 3.05B 235M 230M 9.62B 192B 143M 123M 117M 106M 199M 13.68B 200M 1.39B 534M 6.96B 538M 526M 22B
Net income 32B 23.87M 20.57M 19.48M 17.65M 33.12M 2.28B 33.29M 231M 88.95M 1.16B 89.66M 87.69M 3.67B 119B 88.78M 76.49M 72.43M 65.65M 123M 8.48B 124M 860M 331M 4.31B 333M 326M 13.63B
Net Debt -185B -138M -119M -113M -102M -191M -13.19B -192M -1.34B -514M -6.71B -518M -507M -21.2B -304B -227M -195M -185M -168M -315M -21.67B -316M -2.2B -845M -11.02B -852M -833M -34.83B
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
57
Date Price Change Volume
11/09/26 ₩34,900.00 -1.55% 74,822
10/09/26 ₩35,450.00 +1.87% 114,415
09/09/26 ₩34,800.00 -0.71% 88,800
08/09/26 ₩35,050.00 -2.50% 84,729
07/09/26 ₩35,950.00 -1.78% 108,920
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
34,900.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+114.90%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A039200 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!